A Study of Abemaciclib (LY2835219) in Healthy Participants With and Without Food
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the amount of abemaciclib that reaches the blood
stream and how long the body takes to get rid of it when given with and without food. In
addition, the safety and tolerability of the study drug will be evaluated. Information about
any side effects that may occur will also be collected. The study will last about 43 days for
each participant, not including screening.